Calgary firm advances new trial, manufacturing of mRNA vaccine for COVID-19
The company says it has signed a $90-million, five-year contract with Emergent Biosolutions to make part of the drug substance, and also to fill and finish the vaccine, at its Winnipeg manufacturing plant.